AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses

Published:2016-04-18 Issue:9 Volume:51 Page:1245-1248
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gillissen M A,de Jong G,Levie S E,Yasuda E,Bakker A Q,Evers L M,Pals S T,Huisman C,van Helden P M,Spits H,Hazenberg M D

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201690.pdf

Reference19 articles.

1. Blazar BR, Murphy WJ, Abedi M . Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443–458.

2. Jenq RR, van den Brink MRM . Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer 2010; 10: 213–221.

3. Ruggeri L . Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.

4. Wu CJ, Yang XF, McLaughlin S, Neuberg D, Canning C, Stein B et al. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest 2000; 106: 705–714.

5. Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004; 103: 353–359.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT;The Lancet Haematology;2024-06

2. Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation;Immuno-Oncology Technology;2020-09

3. Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies;European Journal of Haematology;2019-09-02

4. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia—A case report;Hematology/Oncology and Stem Cell Therapy;2019-09

5. Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease—single center experience;Annals of Hematology;2019-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3